AC FORUM 2025

Thursday, April 3, 2025 5:30 PM Thursday, April 3, 2025 6:30 PM America/New_York WELCOME RECEPTION & POSTER PRESENTATIONS Arlington Ballroom, Salons 4-6 aYaMRExkLzQZmPlsLmNx65599

WELCOME RECEPTION & POSTER PRESENTATIONS

Poster Session

Thursday, April 3, 2025

5:30 PM - 6:30 PM

Arlington Ballroom, Salons 4-6

UTILIZATION OF A DIRECT ORAL ANTICOAGULANT (DOAC) POPULATION MANAGEMENT TOOL (PMT): STANDARDIZING ASSESSMENT OF LIVER FLAGS

Christina M Bookwalter, Michelle Anderson, Heather Poepping, Julie Spenner

COMPARISON OF ANTICOAGULATION CONTROL AND OUTCOMES BETWEEN USUAL MEDICAL CARE AND PHARMACIST-LED ANTICOAGULATION SERVICE IN AMBULATORY PATIENTS TAKING WARFARIN AT TERTIARY HOSPITAL IN ETHIOPIA: A QUASI-EXPERIMENTAL STUDY

Tamrat Assefa Tadesse, Amha Gebremedhin, Dejuma Yadeta, Legese Chelkeba, Teferi Gedif

AUTOMATION, EXPANSION AND OPTIMIZATION OF AN EMERGENCY DEPARTMENT TRANSITION OF CARE PROGRAM FOR OUTPATIENT MANAGEMENT OF ACUTE VENOUS THROMBOEMBOLIC DISEASE: EXPERIENCE WITH OUR FACILITATING ANTICOAGULATION FOR SAFER TRANSITIONS (FAST) ENTERPRISE HEALTH SYSTEM PROGRAM.

Lynda J Thomson, Menaka Suri, Geno J Merli, Huelena Nguyen

IMPLEMENTING & INTEGRATING A VIRTUAL NURSE-LED ANTICOAGULATION CLINIC CARE TEAM

Kristin D.F. Negley, Gina M. Foster, Jeffrey P. Timm, Angela Mattson

IMPROVING THE PERIOPERATIVE PROCESS FOR PATIENTS PANAGED BY A PHARMACIST-PUN ANTICOAGULATION CLINIC

Sanela Lekic, Katie Kish, Kayla Woicehovich, Amita Pandya, Brandy Ungham, Nicole Bonnallie, Angela Sanders

CONTINUED ASSESSMENT OF A DIRECT ORAL ANTICOAGULANT (DOAC) DASHBOARD

Nghi Ha, Nhan Hoang, Liza Renner, Erin Mouland, Michael Lanham, Geoff Barnes

IMPLEMENTATION OF A WARFARIN PATIENT SELF-MANAGEMENT PROGRAM IN PATIENTS ON CHRONIC WARFARIN THERAPY

Allison Dery, Ashley Varela-Martinez, Charlene Nash, Darla Althizer

IMPLEMENTATION OF A CENTRALIZED DIRECT ORAL ANTICOAGULANT SURVEILLANCE PROGRAM

Sandra Hedin, Melissa Fontana, Briana Ballister

THE IMPACT OF A VA DOAC POPULATION MANAGEMENT TOOL FLAG FOR CONCURRENT ANTIPLATELETS

Allison/B Riendeau, Christi/A Albert

SAFETY HUDDLES IN ANTICOAGULATION CLINIC PRACTICE

Abbie M Helmrick, Christina M Bookwalter

ADHERENCE TO DIRECT ORAL ANTICOAGULANTS AMONG U.S. VETERANS WITH ATRIAL FIBRILLATION IN THE ERA OF THE VETERAN HEALTH ADMINISTRATION DOAC POPULATION MANAGEMENT TOOL

Arthur Allen, Shardool Patel, Brian Sauer, Bishoy Ragheb

POPULATION MANAGEMENT TOOLS FACILITATE ANTICOAGULATION STEWARDSHIP WITHIN VETERANS HEALTH ADMINISTRATION

Arthur Allen, Briana Ballister, Bishoy Ragheb, Geoffrey Barnes

RISK MITIGATION OF GASTROINTESTINAL BLEEDING IN PATIENTS CO-PRESCRIBED ANTIPLATELETS WITH ORAL ANTICOAGULANTS: VISN 8 ANTICOAGULATION STEWARDSHIP PROTON PUMP INHIBITOR INITIATIVE

David Parra, Jeffery L Kibert II, Natalie R Ciccone, Litzalee Camacho-Vega, Joseph Capriola, Jennifer L Crowley, Joseph J Fierro, Alida Marrero-Hernandez, Maria J Irias, Robert D Stewart, Jaclyn Stoppi, Elyse C Wilson, Laura K Vinieratos, for the VISN 8 Pharmacy Anticoagulation Workgroup

REAL WORLD EXPERIENCE WITH USE OF COAGULATION FACTOR VIIA (RECOMBINANT)-JNCW (SEVENFACT) AT AN ACADEMIC MEDICAL CENTER

Alyssa R George, Katelyn W Sylvester, Dareen M Kanaan, Prabashni Reddy, Jean M Connors, Nathan T Connell

ANTICOAGULATION STEWARDSHIP IN ACTION: THE EXPERIENCE OF A LATIN AMERICAN CENTER IN IMPROVING ADHERENCE AND REDUCING COMPLICATIONS

Mayra A Arenas-Beltran, Paula A Ruiz-Talero, Oscar Muñoz, Karen Navarro, Pilar Alarcón, Alice Salamanca

B10

EVALUATION OF ANTITHROMBOTIC USE IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH A GASTROINTESTINAL BLEED

Tara K. Lech, Caitlyn Leonard, Corinne M. Bertolaccini

B11

ASSESSING THE IMPACT OF AN INPATIENT ANTICOAGULATION STEWARDSHIP PROGRAM

Amy Ives, Harriet Kusi

B12

IMPLEMENTATION OF A CLINICAL SURVEILLANCE TOOL FOR DIRECT ORAL ANTICOAGULATION MONITORING IN THE OUTPATIENT SETTING

Kosha Patel, Alissa Nathans, Drew Armstrong, Jennifer Campbell

B13

EVALUATION OF HEPARIN NOMOGRAM PERFORMANCE IN UNDER- AND OVERWEIGHT PATIENTS

Ines P. Medel, Vi Gilmore , Katie Dane, John Lindsley, Catherine Kiruthi , Michael Streiff

B14

PHARMACY-DRIVEN ANTITHROMBOSIS STEWARDSHIP CONSULTATION TO PROMOTE SAFE, TIMELY DISCHARGE OF LOW-RISK VENOUS THROMBOEMBOLISM FROM THE EMERGENCY DEPARTMENT (PASS ON ADMIT STUDY)

Juan D Castellanos, Preeyaporn Sarangarm, Lisa Koselke, Allison E Burnett

B15

ANTITHROMBOSIS STEWARDSHIP AS A KEY DRIVER WITHIN A VTE CENTER OF EXCELLENCE: THE AMBITION STUDY

Angela Martoccia Grabazs, Preeyaporn Sarangarm, Allison E Burnett

B16

THE CURRENT LANDSCAPE OF ANTICOAGULATION (AC) STEWARDSHIP IMPLEMENTATION AROUND THE WORLD: AN INTERNATIONAL SURVEY

Nancy L. Shapiro, Grace A. McGee, Allison E. Burnett

B17

ANTICOAGULATION STEWARDSHIP USING A DIRECT ORAL ANTICOAGULATION DASHBOARD TO REDUCE INCORRECT PRESCRIBING.

Jeffrey Lee, Stacy Ellsworth, Brian Haymart, Gregory Krol, Bevelry Stallings, Noelle Ryan, Michael Lanham, Geoff Barnes, Scott Kaatz

ANTICOAGULATION STEWARDSHIP PROGRAM IMPACT ON DEPRESCRIBING INAPPROPRIATE ANTIPLATELET THERAPY FOR PATIENTS ON ORAL ANTICOAGULATION THERAPY IN THE OUTPATIENT SETTING

Josey Poppens, Thaddaus Hellwig, Shannon Wegleitner, Sara Zochert, Amanda Owen, Michael Gulseth

PHARMACIST EMPOWERMENT, MANDATORY 4T SCORING AND REAL-TIME EHR ALERTS TO OPTIMIZE ANTITHROMBOSIS STEWARDSHIP AROUND DIAGNOSIS AND MANAGEMENT OF HEPARIN INDUCED THROMBOCYTOPENIA: THE PERSISTENT STUDY

Shruti N Karanth, PharmD, Allison Burnett, PharmD, PhC, CACP, Preeyaporn Sarangarm, PharmD, BCEMP, Chelsea Booker, PharmD, MBA, BCPS

STEWARDSHIP ROLE IN THE PERIPROCEDURAL MANAGEMENT OF PATIENTS WITH HEMOPHILIA A BEFORE AND AFTER INTRODUCTION OF EMICIZUMAB

Daniel Cartagena-Sergenian, Dareen M Kanaan, Katelyn W Sylvester, Jean M Connors, Nathan T Connell

THE IMPACT OF PROSPECTIVE REVIEW OF PLATELET FACTOR 4 TESTING PRACTICES FOR SUSPECTED HEPARIN-INDUCED THROMBOCYTOPENIA: AN ANTITHROMBOTIC STEWARDSHIP INITIATIVE

J. Harrison Badalamenti, John Lindsley, Jessica Crow, Jessica Chasler, Ivo Francischetti, Rakhi Naik, Michael Streiff, Jennifer Yui, Katie Dane

ANTIPLATELET AND ANTICOAGULANT BLEEDING RISK REDUCTION: A COLLABORATIVE APPROACH

Lauren Jones, Megan Grischeau, Alaa Minkara, Brandon Cave, Briana Ballister, Melissa Fontana, Sandra Hedin

ASPIRIN UTILIZATION IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ON ORAL ANTICOAGULANTS IN A LARGE ACADEMIC MEDICAL CENTER

Morgan Quinn, Andrew Galascio, Jennifer Mazur, Sienna Miller, Joli Fermo, Aulbrey Drisaldi, David Cruse, Emily Ware

IMPACT OF TRANSITIONING FROM ALTEPLASE TO TENECTEPLASE FOR ACUTE ISCHEMIC STROKE

Gabriela Dominguez Arocho, Allison Bouwma, Jessica Brochu, Mathew Jones

COMPARATIVE EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS COMPARED WITH WARFARIN IN PATIENTS WITH LOW BODYWEIGHT WHO HAVE ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Mohamed Elshafei, Ahmed El-Bardissy, Muhammad Salem, Mohamed Abdelmoneim, Mohammed Danjuma

STROKE PREVENTION IN ATRIAL FIBRILLATION AND FLUTTER - TARGETING THE UNTREATED PATIENTS IN VETERANS HEALTH ADMINISTRATION WITH A PHARMACISTS-LED, MULTI-CENTER ELECTRONIC HEALTH RECORD INTERVENTION

Arthur Allen, Jeffery Kibert, Geoffrey Barnes, Michael Dyal, Paul Varosy, David Parra

ANTITHROMBOTIC PRESCRIBING PRACTICES IN PATIENTS WITH ATRIAL FIBRILLATION PRESENTING WITH ACUTE ISCHEMIC STROKE WHILE ON ORAL ANTICOAGULATION

Corinne M. Bertolaccini, Collin J. Culbertson, Yixin Kong, Zhibang Lin, Tara K. Lech

IMPACT OF AMIODARONE EXPOSURE ON APIXABAN PHARMACOKINETICS IN HOSPITALIZED PATIENTS

Samantha Kolowrat, BS, Chazmyn Riley, PharmD, Kevin Lam, PharmD, Lynda Thomson, PharmD, Douglas Stickle, PhD, Thomas Hyson, PharmD, Gil Berreby, BS, Walter Kraft, MD

IMPACT OF FOOD INSECURITY ON ANTICOAGULATION QUALITY AMONG PATIENTS RECEIVING WARFARIN AT A SAFETY NET ACADEMIC CENTER.

Yva Gauthier, Alyssa E. Utz, Mikhail Y. Akbashev, Kapil Chandora, Feyi M. Ward

SOCIAL DETERMINANTS OF HEALTH BARRIERS WITHIN AN ANTITHROMBOSIS CLINIC

Hannah Ayers, Karen C. Thomas, Lauren Wilcox, Ellen Uppuluri

ATTRIBUTABLE RISK OF BLEEDING IN PULMONARY EMBOLISM (PE): A COMPARATIVE STUDY OF CONTEMPORANEOUS CONTROL, SYMPTOMATIC PE, AND ASYMPTOMATIC PE

Sophie Samuel, Jamie SC Beck, Vi Tran

FEEL FREE TO CHECK AT3 - BASELINE ANTITHROMBIN III ACTIVITY AND TIME TO THERAPEUTIC ANTICOAGULATION IN MECHANICAL CIRCULATORY SUPPORT

Dalia Kassabieh, Benjamin August, Mathew Jones, Kristin Griebe

EVALUATION OF A PROTOCOL FOR HEPARIN INITIATION IN PATIENTS TRANSITIONING FROM ORAL FACTOR XA INHIBITORS

Carla E. Staresinic, Katie L. Willenborg, Stephanie D. Eickman, Kourtney A. Peterson

THE EFFECT OF INDIVIDUALIZED INTRAVENOUS HEPARIN DOSING ON ACTIVATED PARTIAL THROMBOPLASTIN TIME VALUES IN NEUROCRITICAL CARE PATIENTS

Keri S. Kim, Mya Fitzpatrick, Ruchi Patel, Nishita Gandhi, John Garofalo, Jeffrey J. Mucksavage

DERIVATION AND VALIDATION OF A PHARMACOGENETIC GUIDED WARFARIN DOSING ALGORITHM IN AN ARAB POPULATION RESIDING IN QATAR

Amr Fahmi, Ahmed El Bardissy, Mohamed Saad, Mohamed Nabil, Loulia Bader, Mohamed Kassem, Ahmed Mahfouz, Osama Abdelsamad, Abdelnasser Elzouki, Hazem Elewa

ARGATROBAN USE IN THERAPEUTIC PLASMA EXCHANGE (TPE): A CASE OF DYNAMIC ANTICOAGULATION RESPONSE

Jennifer E Stanton, Alexander R Nixon

DIRECT ORAL ANTICOAGULANTS IN END STATE RENAL DISEASE

Avani Prabhu, Bhakti Singh, Anvi Peddi, Haritha Pabbathi, Atul Laddu, Jawed Fareed

HISTORY OF INTRODUCTION OF DIRECT ORAL ANTICOAGULANTS AND MECHANISM OF ACTION

Arya Karmarkar, Ashutosh Barde, Anterpreet Dua, Atul Laddu, Jawed Fareed

WORLDWIDE HEPARIN SHORTAGE

Maanas Deodhar, Surabhi Fadnavis, Atul Laddu, Jawed Fareed

WARFARIN AND GLP-1 RECEPTOR AGONIST INTERACTION EFFECTS ON TIME IN THERAPEUTIC RANGE

Phillip Anjum, Mikhail Y Akbashev, Alyssa Utz, Sydney Kisala

MAKING IT COUNT: EVALUATING AN INTERVENTION TO INCREASE USABILITY OF FACTOR XA INHIBITOR ANTI-XA LEVELS

Emily Tisler, Sara Zochert

ASSESSING ANTICOAGULATION STATUS OF A PATIENT WITH APS USING CHROMOGENIC FACTOR X TESTING

Katelyn N. Bell

EVALUATION OF HEPARIN-INDUCED THROMBOCYTOPENIA TESTING TO IMPROVE ANTICOAGULATION STEWARDSHIP IN AN ACUTE CARE SETTING

Yelena Samofalova, PharmD, Nicole Thurnherr, PharmD, Micaela Powner, PharmD, BCPS, Jillian Searle, PharmD, BCPS, BCACP, Michelle Byram, BS Pharm, CACP

EVALUATION OF HEMOGLOBIN MONITORING FREQUENCY IN PATIENTS ON ANTICOAGULATION THERAPY

Liana Ha, Saira Mirza, Alyssa E. Utz, Salman Hasham, Mikhail Y. Akbashev

REAL-WORLD IMPLEMENTATION OF LATEX IMMUNOTURBIDIMETRIC PLATELET FACTOR 4 ASSAY FOR HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS AT A LARGE ACADEMIC MEDICAL CENTER

Dareen M Kanaan, Gabriella C Torres, Allison L Zhang, Katelyn W Sylvester, Daniel Dees, Elisabeth M Battinelli, Jean M Connors

CLINICAL PERFORMANCE OF A NOVEL POINT-OF-CARE COAGULOMETER, THE PEROSPHERE CLOTCHEK&TRADE;, FOR THE DOACS

S. H. Bakhru, X. Jiang, L. Chen, D. Osmani, A. Balaj, K. Kronen, D. Mootoo, F. LaDuca, J. Ansell

COMPARISON OF WARFARIN TIME IN THERAPEUTIC RANGE BEFORE AND AFTER HOME METER ENROLLMENT

Kaitlyn P. Coggsdale, PharmD, CPP, Sarah L.E. Russell, PharmD, BCACP, CPP, Mattlyn T. Staley, PharmD, CPP, Kristin D. Bradley, PharmD, BCPS, CPP, Anne M. Rodino, PharmD, BCCP, CPP

IMPACT OF HOME TESTING ON INR CONTROL AND ADVERSE EVENTS IN BLACK PATIENTS ON WARFARIN FOR ATRIAL FIBRILLATION OR VENOUS THROMBOEMBOLSIM

Brindha Rajakumar, Xiaowen Kong, Brian Haymart, Scott Kaatz, Gregory Krol, Mona Ali, Noelle Ryan, Stacy Ellsworth, Beverly Stallings, Tina Alexandris-Souphis, Amy DeLellis, James B. Froehlich, Geoffrey D. Barnes

POINT-OF-CARE INR MONITORING FOR PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

Morgan T Quinn, Tara Mohit, Amy Hebbard, Rebecca Chapin, Brittany Cogdill

DIFFERENCES IN TYPES OF THROMBOSES AND RISK FACTORS IN MALES VERSUS FEMALES IN ADOLESCENT THROMBOEMBOLISM IN THE THROM-PED REGISTRY

Lakshmi Srivaths, Natalie Montanez, Heleen van Ommen

INCREASED NEONATAL MORTALITY AND INCREASING RATE OF CEREBRAL VENOUS SINUS THROMBOSIS IN HOSPITALIZED CHILDREN: A PEDIATRIC HEALTH INFORMATION SYSTEM DATABASE STUDY

Jiasen He, Natalie Montanez, Stuart Fraser, Audrey Barnett, Christin Silos, Keely Smith, Lakshmi Srivaths

H3J

PARENTERAL BRIDGING PRACTICES AND OUTCOMES IN PATIENTS ON WARFARIN FOR MECHANICAL HEART VALVES AND VENOUS THROMBOEMBOLISM

Rachel Tang, Xiaowen Kong, Brian Haymart, Abigail Gredell, Scott Kaatz, Gregory Krol, Mona Ali, Noelle Ryan, Stacy Ellsworth, Beverly Stallings, Amy DeLellis, James B. Froehlich, Geoffrey D. Barnes

COMPARATIVE ANALYSIS OF PERIOPERATIVE MANAGEMENT OF ANTIPLATELET AGENT GUIDELINES ACROSS US INSTITUTIONS

Ming Y Lim, Jacob Cogan, Caroline Cromwell, Manila Gaddh, Radhika Gangaraju, Colleen Morton, Andrew Peseski, Rishabh Singh, Ishan Tatake, Kimberley Youkhana, Lisa Baumann Kreuziger

EVALUATION OF A PHARMACIST-LED PERIOPERATIVE ANTITHROMBOTIC MANAGEMENT SERVICE

Nghi Ha, Liza Renner, Erin Mouland, Denise Sutter-Long, Anisa Bici

OPTIMIZING PERIOPERATIVE ANTICOAGULATION MANAGEMENT: IMPACT OF A CLINICAL PHARMACIST PRACTITIONER MANAGED CLINIC ON PATIENT SAFETY AND CARE QUALITY

Ruby O. Doan, April Y. Allen

PERI-PROCEDURAL WARFARIN BRIDGING EVALUATION FOR PATIENTS WITH ATRIAL FIBRILLATION ENROLLED IN AN ANTICOAGULATION MANAGEMENT SERVICE

Hamza H Sinan, Katelyn W Sylvester, Mengyan Li, Ellie M Kang, Rebecca H Chow, Jean M Connors

D3K

THE CHANGING LANDSCAPE OF STROKE PREVENTION IN SUBCLINICAL ATRIAL FIBRILLATION AND A POTENTIAL PATH FORWARD IN THE VETERAN POPULATION: A POPULATION HEALTH ANTICOAGULATION STEWARDSHIP INITIATIVE

Arthur Allen, David Parra, Jeffery Kibert

DEVELOPING AN INNOVATIVE CLINICAL DECISION SUPPORT APP FOR ENHANCED PERIPHERAL ARTERY DISEASE MANAGEMENT

Kelly M. Rudd, Jennifer Glen, Tim Michalski

AVAILABILITY, PRICING, AND AFFORDABILITY OF ANTITHROMBOTICMEDICINES IN ADDIS ABABA, ETHIOPIA: IMPLICATIONS FOR HEALTH POLICY

Tamrat Assefa Tadesse, Selam Birhanu, Melaku Tileku Tamiru, Hanan Muzeyin Kedir

B9L

NONADHERENCE TO EARLY DISCHARGE IN LOW-RISK PULMONARY EMBOLISM: INSIGHTS FROM AN ANTICOAGULATION STEWARDSHIP PROGRAM IN LATIN AMERICA

Santiago Mendez Salazar, Paula Ruiz-Talero, Oscar M Munoz, Pilar Alarcon Robles, Karen Navarro Perez, Alice Salamanca

G2L

EVOLUTION OF AN ELECTRONIC HEALTH RECORD-BASED ALERT TO OPTIMIZE VENOUS THROMBOEMBOLISM PROPHYLAXIS

Mikhail Y Akbashev, MD, FACP1, Alyssa Utz, PharmD, BCPS, Phillip Anjum, MD, MS, Stacey M. Watkins, MD, PhD, FACP1, Michael Mattaliano, PharmD, Palak Patel, MS, PhD, Debbie Vigliotti, PharmD, LSSGB, Mara L. Schenker, MD, MBA, Bhavin B. Adhyaru MD, MS, FACP

EVALUATION OF CURRENT OUTPATIENT DOAC MANAGEMENT PRACTICES WITHIN TRINITY HEALTH GRAND RAPIDS

Ashlyn Kiebach, Kristen Eid, Daniel Boldt, Lindsey Westerhof

L10

PATIENT COMPLIANCE WITH ASPIRIN AND RIVAROXABAN POST ELECTIVE JOINT REPLACEMENT SURGERY: A QUALITY ASSURANCE INITIATIVE

Laurie A Sardo, Julia A Bayadinova, Emma K Sardo

THROMBOPHILIA SCREENING IN INPATIENTS: A REVIEW OF TESTING APPROPRIATENESS AND CLINICAL IMPACT IN A TERTIARY HOSPITAL IN QATAR

Osama Abdelsamad, Dania Alkhiyami, Syed Yameen Hasan, Eman Alhmoud, Rasha Al Anany

RURAL IMPROVEMENTS IN VENOUS THROMBOSIS TREATMENT IN OKLAHOMA: THE RIVETT-OK INITIATIVE

Kelly M. Rudd, Jonathan Lowe, Bradley Anderson, Mike Shea, Jared Droze

TO PRESCRIBE OR DEPRESCRIBE: ANTIPLATELET DISCONTINUATION VERSUS PROTON PUMP INHIBITOR (PPI) ADDITION IN VETERANS WITH COMBINED ANTITHROMBOTIC THERAPY

Laura Calderon-Lugo, Litzalee Camacho-Vega, Jennifer Crowley, Marina Babilonia-Leon

HEPARIN MANAGEMENT - THE ULTIMATE GOLDILOCKS DILEMMA: A QUALITY IMPROVEMENT PROJECT

Malarvizhi Narayanan, Sarah Lake-Wallace, Samuel Akinyele, Teresa Allison, Julin Mathew, Megan Anderson, Latosha Mitchell, Diane Vo, Sue Thomas, Nautam Ganatra

IMPROVING THE ANTICOAGULATION PROGRAM ENROLLMENT PROCESS: A COLLABORATION BETWEEN UNLICENSED ASSISTIVE PERSONNEL AND REGISTERED NURSES TO IMPROVE PRACTICE AND PATIENT CARE

Kristin D.F. Negley, Gina M Foster, Robin Beaupre, Kelly Breck, Amanda Schulz, Marissa Ruechel, Desiree Neumann

EVALUATING THE CLINICAL UTILITY AND APPROPRIATENESS OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATES FOR ANTICOAGULATION REVERSAL AT AN URBAN, COMMUNITY ACADEMIC HOSPITAL

Nicole Thurnherr, PharmD, Youssef Bessada, PharmD, BCPS, BCCP

EVALUATION OF COMPLIANCE WITH RECOMMENDATION TO TAKE RIVAROXABAN WITH FOOD

Nghi Ha, Erin Mouland, Denise Sutter-Long, Anisa Bici, Liza Renner

EVALUATION OF VARIOUS TREATMENT STRATEGIES FOR ACQUIRED HEMOPHILIA A

Agnes Musyoka, Joseph Mazur, Benjamin Djulbegovic, Jennifer Mazur, Julie Ehret, Joli Fermo, Sienna Miller

VARIATION IN ANTICOAGULANT HEMORRHAGE MANAGEMENT GUIDELINES FOR FACTOR-XA INHIBITORS: A SURVEY AND ANALYSIS OF U.S. ACADEMIC INSTITUTIONS

Rishabh Singh, Ishan J Tatake, Joseph Sibley, Radhika Gangaraju, Karlyn A Martin, Rachel P Rosovsky, Diana Marie Byrnes, Ming Y Lim, Manila Gaddh, Jacob Cogan, Kimberley Youkhana, Lisa Baumann Kreuziger, Andrew M Peseski

AN ANALYSIS OF THE USE OF ANDEXANET ALFA AT THE UNIVERSITY OF UTAH HOSPITAL.

James R. Gustat, Aubrey E. Jones, Daniel M. Witt

EVALUATION OF ANTISEIZURE MEDICATION IMPACT ON EFFICACY OF DIRECT ORAL ANTICOAGULANTS

Corinne M. Bertolaccini, Lauren Bronson, Tara K. Lech

EVALUATION OF DIRECT ORAL ANTICOAGULANT ELIGIBILITY AND PRESCRIBING FOR PRIMARY VENOUS THROMBOEMBOLISM PREVENTION IN HIGH-RISK AMBULATORY PATIENTS WITH CANCER

Michelle Wasan, Stefanie Houseknecht, Kelli Rourke, Charita Marthone, Michael Streiff, Daniel Laheru, Lei Zheng, Kathryn Dane

SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH BODY MASS INDEX &GE;40 KG/M2

Anisa Bici, Denise Sutter-Long, Liza Renner, Erin Mouland, Nghi Ha

SAFETY AND EFFICACY OF APIXABAN IN PATIENTS RECEIVING HEMODIALYSIS COMPARED TO PATIENTS WITH MODERATE RENAL DYSFUNCTION

Denise Sutter-Long, Anisa Bici, Erin Mouland, Liza Renner, Nghi Ha

SAFETY AND EFFICACY OF THE USE OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH A HISTORY OF BARIATRIC SURGERY

Nicholas Shabanowitz, Kayla Popova, Michelle Schultz, Nghi Ha

FAT-SPECIFIC S6 KINASE GENE INHIBITION: A NOVEL STRATEGY TO IMPROVE METABOLIC HEALTH AND ANTICOAGULATION OUTCOMES IN DIABETES-ASSOCIATED THROMBOSIS

Siddarth Suresh

WOMEN IN SCIENCE

Isha Jayakumar, Nila Jayakumar, Srishti Sawant, Gitika Aggarwal, Atul Laddu, Jawed Fareed

THE YOUTH IS OUR FUTURE, AND THE FUTURE IS HERE

Omkar Garud, Naga Sahithi Rajuladevi, Sonika Tatipalli, Atul Laddu, Jawed Fareed

DEFICITS IN WARFARIN DISCHARGE PLANNING: IMPROVING TRANSITIONS OF CARE FOR PATIENTS ON WARFARIN AT A COMMUNITY TEACHING HOSPITAL

Krista Luck, Amira Carter, Sesalie Rhinehart, Elizabeth Ramsaur, Christie Dresback

PATIENT-EDUCATION VIDEO DEVELOPMENT AND IMPLEMENTATION

Audrey Socha, Brian Schlitt, Stephanie Neilson, Deborah Gillard, Janelle Juul, Courtney Wack, Aaron Glueckstein, Ceanne Simmelink, Susan Hahn, Alyssa Schaller

CREATION OF PATIENT SELF-MANAGED WARFARIN PROGRAM WITHIN AN ANTICOAGULATION CLINIC

Julia Kluck, Jennifer Hardman, Lisa Baumann Kreuziger, Hannah Breidenbach, Eric Mendez-Michler, Michelle Te Ronde, Jesse Kutz, Rebecca Wong

ANALYSIS OF XA LEVELS AND PTTS DURING THE FIRST 48 HOURS OF ANTICOAGULATION WITH UNFRACTIONATED HEPARIN INFUSION

Kaitlyn Loi

EVALUATING THE EFFECTIVENESS AND TOLERABILITY OF UFH VS. LMWH FOR VTE PREVENTION IN UNDERWEIGHT PATIENTS: A RETROSPECTIVE COHORT STUDY

Mohammad T Alashqar, Pardis Niami, Adam Cuker

ELEVATION OF D-DIMER WITHOUT ANY EVIDENCE OF VENOUS THROMBOEMBOLISM: WHAT IS YOUR INTERPRETATION?

Om Joshi, Riddhi Surve, Deepa Nagarajan, Atul Laddu, Jawed Fareed